CAROL SANDERS: Open Payments
NPI 1801237441 · GASTONIA, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$676 in 36 payments from 13 companies in 2025. Trend: 2023 $900 · 2024 $839 · 2025 $676
Food & beverage: $676
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 4 | $96 |
| Aimmune Therapeutics, Inc. | 5 | $91 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $67 |
| ABBVIE INC. | 3 | $64 |
| Madrigal Pharmaceuticals | 2 | $60 |
| Janssen Biotech, Inc. | 2 | $60 |
| GENZYME CORPORATION | 2 | $53 |
| Phathom Pharmaceuticals, Inc. | 6 | $49 |
| Celltrion USA Inc. | 3 | $49 |
| QOL Medical, LLC | 2 | $31 |
Products named: ZENPEP, ENTYVIO, REZDIFFRA, TREMFYA, DUPIXENT, VOQUEZNA, VEGZELMA, RINVOQ.
Industry payments across NC — which companies pay providers there.
